Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies

I.J. Gallagher, N.A. Stephens, A.J. MacDonald, R.J.E. Skipworth, H. Husi, C.A. Greig, J.A. Ross, J.A. Timmons, K.C.H. Fearon

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Purpose: The mechanisms underlying muscle wasting in patients with cancer remain poorly understood, and consequently there remains an unmet clinical need for new biomarkers and treatment strategies.

Experimental Design: Microarrays were used to examine the transcriptome in single biopsies from healthy controls (n = 6) and in paired biopsies [pre-resection baseline (weight-loss 7 and 8 month post-resection follow-up (disease-free/weight-stable for previous 2 months)] from quadriceps muscle of patients with upper gastrointestinal cancer (UGIC; n = 12).

Results: Before surgery, 1,868 genes were regulated compared with follow-up (false discovery rate, 6. Ontology analysis showed that regulated genes belonged to both anabolic and catabolic biologic processes with overwhelming downregulation in baseline samples. No literature-derived genes from preclinical cancer cachexia models showed higher expression in baseline muscle. Comparison with healthy control muscle (n = 6) revealed that despite differences in the transcriptome at baseline (941 genes regulated), the muscle of patients at follow-up was similar to control muscle (2 genes regulated). Physical activity (step count per day) did not differ between the baseline and follow-up periods (P = 0.9), indicating that gene expression differences reflected the removal of the cancer rather than altered physical activity levels. Comparative gene expression analysis using exercise training signatures supported this interpretation.

Conclusions: Metabolic and protein turnover?related pathways are suppressed in weight-losing patients with UGIC whereas removal of the cancer appears to facilitate a return to a healthy state, independent of changes in the level of physical activity.

Original languageEnglish
Pages (from-to)2817-2827
Number of pages10
JournalClinical Cancer Research
Volume18
Issue number10
DOIs
Publication statusPublished - 1 May 2012

Fingerprint Dive into the research topics of 'Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies'. Together they form a unique fingerprint.

  • Cite this

    Gallagher, I. J., Stephens, N. A., MacDonald, A. J., Skipworth, R. J. E., Husi, H., Greig, C. A., Ross, J. A., Timmons, J. A., & Fearon, K. C. H. (2012). Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies. Clinical Cancer Research, 18(10), 2817-2827. https://doi.org/10.1158/1078-0432.CCR-11-2133